General Announcement::Company Statement

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Nov-2024 17:12:25
Status
New
Announcement Sub Title
Company Statement
Announcement Reference
SG241110OTHR8XDR
Submitted By (Co./ Ind. Name)
Akhilesh Nand - Biocon Biologics Limited
Designation
Company Secretary
Effective Date and Time of the event
11/11/2024 00:00:00
Description (Please provide a detailed description of the event in the box below)
USFDA Classifies Biocon Biologics Biocon Park Site in Bengaluru, India as Voluntary Action Initiated (VAI)

Attachments

BBL_CompanyStatement_10112024_SGX.pdf
Total size =362K